BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25461669)

  • 1. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer.
    LeBlanc TW; Nipp RD; Rushing CN; Samsa GP; Locke SC; Kamal AH; Cella DF; Abernethy AP
    J Pain Symptom Manage; 2015 Apr; 49(4):680-9. PubMed ID: 25461669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
    LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
    Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cancer anorexia-cachexia syndrome: myth or reality?
    Lasheen W; Walsh D
    Support Care Cancer; 2010 Feb; 18(2):265-72. PubMed ID: 19937260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
    Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
    Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
    Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
    Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.
    Nishie K; Yamamoto S; Nagata C; Koizumi T; Hanaoka M
    Lung Cancer; 2017 Oct; 112():25-34. PubMed ID: 29191597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks.
    van der Meij BS; Schoonbeek CP; Smit EF; Muscaritoli M; van Leeuwen PA; Langius JA
    Br J Nutr; 2013 Jun; 109(12):2231-9. PubMed ID: 23153477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health professionals' attitudes toward the detection and management of cancer-related anorexia-cachexia syndrome, and a proposal for standardized assessment.
    Del Fabbro E; Jatoi A; Davis M; Fearon K; di Tomasso J; Vigano A
    J Community Support Oncol; 2015 May; 13(5):181-7. PubMed ID: 26029935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What bothers lung cancer patients the most? A prospective, longitudinal electronic patient-reported outcomes study in advanced non-small cell lung cancer.
    LeBlanc TW; Nickolich M; Rushing CN; Samsa GP; Locke SC; Abernethy AP
    Support Care Cancer; 2015 Dec; 23(12):3455-63. PubMed ID: 25791391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment.
    Mantovani G; Madeddu C; Macciò A; Gramignano G; Lusso MR; Massa E; Astara G; Serpe R
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1651-9. PubMed ID: 15466983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [VEGF in the cancer anorexia-cachexia syndrome in patients with lung cancer].
    Weryńska B; Kosacka M; Gołecki M; Jankowska R
    Pneumonol Alergol Pol; 2006; 74(2):186-90. PubMed ID: 17269367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
    Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
    Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide.
    Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM
    Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer anorexia - cachexia syndrome.
    Muliawati Y; Haroen H; Rotty LW
    Acta Med Indones; 2012 Apr; 44(2):154-62. PubMed ID: 22745148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The incidence and pathogenesis of cancer anorexia-cachexia syndrome in lung cancer].
    Kosacka M; Weryńska B; Gołecki M; Jankowska R; Passowicz-Muszyńska E
    Pneumonol Alergol Pol; 2008; 76(5):360-5. PubMed ID: 19003767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of survival in patients with advanced cancer admitted to home care.
    Mercadante S; Valle A; Porzio G; Aielli F; Adile C; Casuccio A;
    J Pain Symptom Manage; 2013 Jan; 45(1):56-62. PubMed ID: 23017625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial.
    Spigel DR; Hainsworth JD; Burkett ER; Burris HA; Yardley DA; Thomas M; Jones SF; Dickson NR; Scullin DC; Bradof JE; Rubinsak JR; Brierre JE; Greco FA
    Clin Lung Cancer; 2005 Sep; 7(2):127-32. PubMed ID: 16179100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer cachexia assessment: new tools for oncologists.].
    Serpe R; Demurtas L; Puzzoni M; Madeddu C; Scartozzi M
    Recenti Prog Med; 2016 Oct; 107(10):515-524. PubMed ID: 27782227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.